Reed's (REED) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Strategic initiatives in 2024 focused on strengthening financial and operational foundations, including balance sheet reinforcement, operational streamlining, and efficiency enhancements to support long-term growth and profitability.
Net sales declined to $9.7M in Q4 2024 from $11.7M in Q4 2023; full year net sales were $38.0M, down from $44.7M, due to inventory production constraints, vendor credit limits, and short-order shipments.
Gross profit rose over 5x in Q4 to $2.9M, with gross margin improving to 30.0% from 4.0% due to absence of prior-year one-time charges and operational efficiencies.
Completed a $10 million private placement in Q4 2024, providing capital to rebuild inventory, enhance personnel, and expand sales and marketing resources.
Leadership team strengthened with the appointment of a new CFO and VP of Operations, both bringing significant experience in finance, operations, and supply chain management.
Financial highlights
Q4 2024 net sales were $9.7 million, down from $11.7 million in Q4 2023; full year net sales were $38.0 million, down from $44.7 million.
Gross profit for Q4 was $2.9 million (vs. $0.5 million); gross margin improved to 30% from 4%.
Operating loss improved to $3.7 million (negative $0.25/share) in Q4 and $8.1 million for FY 2024, compared to $5.0 million and $9.4 million losses in prior periods.
Cash at year-end was $10.4 million, with total debt reduced to $9.6 million from $27.4 million a year earlier.
Q4 Modified EBITDA was negative $0.7 million, compared to positive $43,000 in Q4 2023.
Outlook and guidance
Inventory rebuild expected to take 60-90 days, positioning the company to capitalize on increased retail demand and drive operational efficiency in 2025.
Launching a new multifunctional beverage line in April 2025, with over 8,000 points of distribution secured.
Anticipates strong momentum from new product launches and expanded distribution, with expectations for top-line growth, margin enhancement, and reduced freight/logistics costs.
Guidance for 2025 revenue targets to be provided in the next quarter.
Uplisting to a major stock exchange is a goal, with sustained operating performance expected to meet requirements.
Latest events from Reed's
- Sequential improvements and new growth initiatives set the stage for margin expansion in 2026.REED
Q4 202525 Mar 2026 - Q2 2024 saw double-digit sales growth, margin gains, and improved but still risky profitability.REED
Q2 20241 Feb 2026 - Net sales and margins dropped, but new funding and restructuring target 2025 recovery.REED
Q3 202414 Jan 2026 - Financial restructuring and product innovation set the stage for strong growth in 2025.REED
The Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Five-year warrants with cash/cashless exercise, anti-dilution, and strong investor protections.REED
Registration Filing4 Dec 2025 - IPO offers shares and warrants to fund growth amid ongoing losses and pending NYSE listing.REED
Registration Filing2 Dec 2025 - Registration enables resale of 18.8M shares after major financings and debt conversions.REED
Registration Filing29 Nov 2025 - Registering 5M shares for resale after $5M placement; expanding in health-focused beverages.REED
Registration Filing29 Nov 2025 - 18.8 million shares registered for resale as company targets growth in natural beverages.REED
Registration Filing29 Nov 2025